factMR-logo.png
Mental Health App Market to Hit US$ 14.72 Billion by 2034: Fact.MR Analysis
April 26, 2024 07:00 ET | FACT.MR
Rockville, April 26, 2024 (GLOBE NEWSWIRE) -- Social, psychological, and behavioural aspects in today’s day and age are primarily leading to development of various mental disorders among...
Logo.png
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
April 25, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, April 25, 2024 (GLOBE NEWSWIRE) -- Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche,...
FB-logo-tag.png
Breathalyzer Market Booms with Technological Advances; Key to Reducing Alcohol-Related Road Deaths
April 25, 2024 09:30 ET | Financial Buzz Media
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- FinancialBuzz.com News Commentary The breathalyzer market has witnessed significant growth and technological advancements in recent years....
Logo.jpg
Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research
April 25, 2024 08:50 ET | DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...
PrimaryLogo_Mango-05.png
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
April 25, 2024 08:30 ET | Mangoceuticals, Inc.
Provides MangoRx with entrance into the non-Rx based, nutraceutical product space for sales on both direct-to-consumer online platforms and through retail locations Dallas, Texas, April 25, 2024...
BioVie Logo.jpg
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
April 25, 2024 08:00 ET | BioVie, Inc.
“Bezisterim” has been approved as the non-proprietary name for NE3107Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation ...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
April 25, 2024 08:00 ET | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
WTW.jpg
WTW Reports First Quarter 2024 Earnings
April 25, 2024 06:00 ET | Willis Towers Watson US LLC
Revenue1 increased 4% to $2.3 billion for the quarter with organic growth of 5% for the quarterDiluted Earnings per Share were $1.83 for the quarter, down 3% over prior yearAdjusted Diluted Earnings...
Global Smart Pills Market
Smart Pills Market, Size and Global Forecast 2024-2032, Featuring Key Players Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis and Otsuka Holdings
April 25, 2024 04:03 ET | Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Smart Pills Market, Size, Global Forecast 2024-2032, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis" report has...
junshi-topalliance-logo.png
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
April 24, 2024 22:11 ET | Junshi Biosciences
SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company...